With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as ...

CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.